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Introduction: The combination of adenosine + lidocaine (adenocaine) and Mg2+
(ALM) has demonstrated cardioprotective properties in models of cardiac arrest
and hemorrhagic shock, and anti-neutrophil effects in vitro. This study evaluates
whether ALM also demonstrates cardioprotective and anti-inflammatory properties
in an endotoxemic porcine model.
Methods: Pigs (37-42kg) received lipopolysaccharide (LPS) at 1 μg/kg/h for 5
hours, and were randomized to: LPS (control) (n=8) or LPS + ALM (n=8). Pigs
received a bolus of ALM at start of LPS infusion followed by 4 hours of infusion.
Cardiac function was evaluated using pressure-volume loops, and inflammation
was assessed by plasma TNF-α and leukocyte superoxide generation.
Results: Infusion of ALM maintained mean arterial pressure (MAP) at a lower level
during the 4 hour infusion period (ALM: 47 ± 1.6 mmHg vs. control: 80 ± 2.9
mmHg, p<0.0001). After discontinuation of ALM, MAP immediately returned to
and was maintained at baseline group values (ALM: 89 ± 5 mmHg vs. control: 86 ±
3 mmHg).
The slope of the end-systolic pressure-volume relationship (ESPVR) was
unchanged during the experiment in both groups. However, a rightward shift of
the volume axis intercept (V0) in the control group indicated decreased
contractility; this shift was not observed in the ALM group (control: -0.1 ± 12 ml
vs. ALM: -32.5 ± 7.6 ml, p= 0.04). Preload recruitable stroke work (PRSW), an
index of overall cardiac performance, decreased in the control group (baseline: 71
± 4: end: 37 ± 4 mmHg · ml / ml), but was preserved in the ALM group (baseline:
72 ± 5; end: 62 ± 4 mmHg · ml / ml, p<0.001 between groups). Diastolic
function evaluated by dP/dtmin (ALM 2221 ± 170 vs. 1793 ± 89 mmHg/sec;
p=0.04) and Tau (ALM 36 ± 1.2 vs. 44 ± 2.2 msec; p=0.007) was also significantly
improved in the ALM group. Peak TNF-α levels were lower in the ALM group (ALM
7653 ± 1092 vs. 11989 ±1057 pg/ml; p=0.01). While neutrophil superoxide
anion release increased by 19 ± 27 % in the control group, it decreased by 74 ±
8% in the ALM group (p=0.0006).
Conclusions: In this porcine model of endotoxemia, ALM improved cardiac
function and reduced the inflammatory response to LPS, thereby extending the
beneficial effects of ALM as reported for cardiac surgery, hemorrhagic shock and
cardiac arrest.
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